Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results , with sales up 18.6% year on year to $306.9 ...

Omnicell reported Q4 2024 revenues of $307 ... Allen Lutz, Bank of America: Asked about hospital budget growth and product revenue ramp. CEO Lipps responded, "Improved financial conditions of ...

Here at Omnicell, we are entering 2025 with a renewed ... Thanks, Allen, for the questions. Yes, I think the hospital financial conditions and providers have continued to improve.

For the current quarter ending in March, Omnicell expects its per-share earnings to range from 15 cents to 25 cents. The company said it expects revenue in the range of $255 million to $265 ...